Free Trial

Canopy Growth (NASDAQ:CGC) Earns "Sell (E+)" Rating from Weiss Ratings

Canopy Growth logo with Medical background

Key Points

  • Canopy Growth has received a "sell (E+)" rating from Weiss Ratings, while Zacks Research upgraded it to a "hold," reflecting mixed sentiment among analysts.
  • The company's stock rose by 5.5% on Wednesday, trading at $1.53 with a significant volume of over 22 million shares.
  • Insider transactions show mixed activity, with CEO Luc Mongeau purchasing shares while insider Christelle Gedeon sold almost 17,000 shares, suggesting cautious sentiment among stakeholders.
  • MarketBeat previews top five stocks to own in November.

Canopy Growth (NASDAQ:CGC - Get Free Report)'s stock had its "sell (e+)" rating restated by Weiss Ratings in a research note issued to investors on Wednesday,Weiss Ratings reports.

Separately, Zacks Research upgraded Canopy Growth to a "hold" rating in a research note on Tuesday, August 12th. One analyst has rated the stock with a Hold rating and three have issued a Sell rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Strong Sell".

Get Our Latest Report on Canopy Growth

Canopy Growth Trading Up 5.5%

NASDAQ CGC traded up $0.08 on Wednesday, hitting $1.53. The company's stock had a trading volume of 22,569,710 shares, compared to its average volume of 12,745,669. Canopy Growth has a 52-week low of $0.77 and a 52-week high of $5.80. The company has a current ratio of 3.07, a quick ratio of 2.12 and a debt-to-equity ratio of 0.59. The company's 50-day simple moving average is $1.38 and its 200 day simple moving average is $1.31. The firm has a market cap of $366.97 million, a P/E ratio of -0.50 and a beta of 0.71.

Canopy Growth (NASDAQ:CGC - Get Free Report) last released its quarterly earnings data on Friday, August 8th. The company reported ($0.14) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.01. The business had revenue of $52.98 million during the quarter, compared to analysts' expectations of $64.98 million. Canopy Growth had a negative return on equity of 89.93% and a negative net margin of 155.76%. Research analysts predict that Canopy Growth will post -2.81 EPS for the current fiscal year.

Insider Buying and Selling

In other Canopy Growth news, insider Christelle Gedeon sold 16,929 shares of Canopy Growth stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $1.74, for a total value of $29,456.46. Following the completion of the sale, the insider owned 368,488 shares of the company's stock, valued at approximately $641,169.12. This trade represents a 4.39% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Luc Mongeau bought 27,469 shares of Canopy Growth stock in a transaction on Monday, September 22nd. The stock was acquired at an average cost of $1.82 per share, with a total value of $49,993.58. Following the acquisition, the chief executive officer owned 812,368 shares in the company, valued at approximately $1,478,509.76. This represents a 3.50% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have sold 50,300 shares of company stock valued at $84,373. 0.16% of the stock is owned by corporate insiders.

Institutional Trading of Canopy Growth

Large investors have recently modified their holdings of the company. Boothbay Fund Management LLC bought a new stake in shares of Canopy Growth in the second quarter worth $30,000. Wealth Enhancement Advisory Services LLC lifted its position in Canopy Growth by 81.3% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 32,336 shares of the company's stock valued at $41,000 after purchasing an additional 14,498 shares in the last quarter. Mackenzie Financial Corp lifted its position in Canopy Growth by 56.5% during the first quarter. Mackenzie Financial Corp now owns 50,413 shares of the company's stock valued at $47,000 after purchasing an additional 18,202 shares in the last quarter. Osaic Holdings Inc. lifted its position in Canopy Growth by 77.6% during the second quarter. Osaic Holdings Inc. now owns 75,335 shares of the company's stock valued at $92,000 after purchasing an additional 32,927 shares in the last quarter. Finally, TD Asset Management Inc lifted its position in Canopy Growth by 47.3% during the first quarter. TD Asset Management Inc now owns 112,721 shares of the company's stock valued at $104,000 after purchasing an additional 36,211 shares in the last quarter. Institutional investors own 3.33% of the company's stock.

Canopy Growth Company Profile

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.